194 related articles for article (PubMed ID: 9515971)
1. A double-blind trial of fluoxetine in pathologic skin picking.
Simeon D; Stein DJ; Gross S; Islam N; Schmeidler J; Hollander E
J Clin Psychiatry; 1997 Aug; 58(8):341-7. PubMed ID: 9515971
[TBL] [Abstract][Full Text] [Related]
2. N-Acetylcysteine in the Treatment of Excoriation Disorder: A Randomized Clinical Trial.
Grant JE; Chamberlain SR; Redden SA; Leppink EW; Odlaug BL; Kim SW
JAMA Psychiatry; 2016 May; 73(5):490-6. PubMed ID: 27007062
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response.
Grant JE; Odlaug BL; Chamberlain SR; Kim SW
J Clin Psychopharmacol; 2010 Aug; 30(4):396-403. PubMed ID: 20531220
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine in pathologic skin-picking: open-label and double-blind results.
Bloch MR; Elliott M; Thompson H; Koran LM
Psychosomatics; 2001; 42(4):314-9. PubMed ID: 11496020
[TBL] [Abstract][Full Text] [Related]
5. Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group.
Zisook S; Peterkin J; Goggin KJ; Sledge P; Atkinson JH; Grant I
J Clin Psychiatry; 1998 May; 59(5):217-24. PubMed ID: 9632030
[TBL] [Abstract][Full Text] [Related]
6. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder.
Tollefson GD; Rampey AH; Potvin JH; Jenike MA; Rush AJ; kominguez RA; Koran LM; Shear MK; Goodman W; Genduso LA
Arch Gen Psychiatry; 1994 Jul; 51(7):559-67. PubMed ID: 8031229
[TBL] [Abstract][Full Text] [Related]
7. Use of Topiramate in Skin-Picking Disorder: A Pilot Study.
Jafferany M; Osuagwu FC
Prim Care Companion CNS Disord; 2017 Jan; 19(1):. PubMed ID: 28129492
[TBL] [Abstract][Full Text] [Related]
8. Continuation treatment of OCD: double-blind and open-label experience with fluoxetine.
Tollefson GD; Birkett M; Koran L; Genduso L
J Clin Psychiatry; 1994 Oct; 55 Suppl():69-76; discussion 77-8. PubMed ID: 7961535
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of fluoxetine in Austrian patients with obsessive-compulsive disorder.
Zitterl W; Meszaros K; Hornik K; Twaroch T; Dossenbach M; Zitterl-Eglseer K; Zapotoczky HG
Wien Klin Wochenschr; 1999 Jun; 111(11):439-42. PubMed ID: 10420495
[TBL] [Abstract][Full Text] [Related]
10. Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder.
Riddle MA; Scahill L; King RA; Hardin MT; Anderson GM; Ort SI; Smith JC; Leckman JF; Cohen DJ
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1062-9. PubMed ID: 1429406
[TBL] [Abstract][Full Text] [Related]
11. Compulsive picking and obsessive-compulsive disorder.
Stein DJ; Hutt CS; Spitz JL; Hollander E
Psychosomatics; 1993; 34(2):177-81. PubMed ID: 8456163
[No Abstract] [Full Text] [Related]
12. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
[TBL] [Abstract][Full Text] [Related]
13. Are fluoxetine plasma levels related to outcome in obsessive-compulsive disorder?
Koran LM; Cain JW; Dominguez RA; Rush AJ; Thiemann S
Am J Psychiatry; 1996 Nov; 153(11):1450-4. PubMed ID: 8890679
[TBL] [Abstract][Full Text] [Related]
14. Self-injurious skin picking: clinical characteristics and comorbidity.
Wilhelm S; Keuthen NJ; Deckersbach T; Engelhard IM; Forker AE; Baer L; O'Sullivan RL; Jenike MA
J Clin Psychiatry; 1999 Jul; 60(7):454-9. PubMed ID: 10453800
[TBL] [Abstract][Full Text] [Related]
15. Open-label escitalopram treatment for pathological skin picking.
Keuthen NJ; Jameson M; Loh R; Deckersbach T; Wilhelm S; Dougherty DD
Int Clin Psychopharmacol; 2007 Sep; 22(5):268-74. PubMed ID: 17690595
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation.
Bodfish JW; Madison JT
Am J Ment Retard; 1993 Nov; 98(3):360-7. PubMed ID: 8292312
[TBL] [Abstract][Full Text] [Related]
18. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group.
Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD
Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120
[TBL] [Abstract][Full Text] [Related]
19. A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.
Hollander E; Soorya L; Chaplin W; Anagnostou E; Taylor BP; Ferretti CJ; Wasserman S; Swanson E; Settipani C
Am J Psychiatry; 2012 Mar; 169(3):292-9. PubMed ID: 22193531
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine treatment of pathologic skin picking: an open-label study.
Grant JE; Odlaug BL; Kim SW
J Clin Psychiatry; 2007 Sep; 68(9):1384-91. PubMed ID: 17915977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
